Arena Pharmaceuticals (Nasdaq: ARNA) is recently down $2.72 to $4.14 on the release of the Merida FDA briefing documents ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE